Efficacy of Eravacycline Versus Best Previously Available Therapy for Adults With Pneumonia Due to Difficult-to-Treat Resistant (DTR) Acinetobacter baumannii
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Pharmacotherapy"
DOI: 10.1177/10600280221085551
Abstract: Background Multidrug-resistant Acinetobacter baumannii remains challenging to treat. Although eravacycline has in vitro activity against this pathogen, there are no studies evaluating outcomes. Objective To assess the efficacy of eravacycline compared with best previously available… read more here.
Keywords: previously available; best previously; therapy; therapy adults ... See more keywords
Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022008097
Abstract: Key Points • Third-line CAR T-cell therapy is unlikely to be cost-effective relative to SOC therapies in unselected patients with R/R FL.• The benefits of CAR T-cell therapy in adults with FL could be clarified… read more here.
Keywords: cell; therapy adults; cost effectiveness; cell therapy ... See more keywords
Update on GH therapy in adults
Sign Up to like & getrecommendations! Published in 2017 at "F1000Research"
DOI: 10.12688/f1000research.12057.1
Abstract: Over the last three decades, short- and long-term observational studies, clinical trials, systematic reviews, and meta-analyses have provided relevant information on the efficacy and safety of growth hormone (GH) replacement therapy in adults with GH… read more here.
Keywords: therapy; therapy adults; update therapy;